Brett Premack - Sirona Biochem Scientific Consultant
SBM Stock | CAD 0.08 0.01 6.67% |
Insider
Brett Premack is Scientific Consultant of Sirona Biochem Corp
Address | 595 Burrard Street, Vancouver, BC, Canada, V7X 1L4 |
Phone | 604 641 4466 |
Web | https://www.sironabiochem.com |
Sirona Biochem Management Efficiency
The company has return on total asset (ROA) of (1.4811) % which means that it has lost $1.4811 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (98.1047) %, meaning that it generated substantial loss on money invested by shareholders. Sirona Biochem's management efficiency ratios could be used to measure how well Sirona Biochem manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Sirona Biochem's Net Tangible Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 1.7 M in 2024, whereas Total Assets are likely to drop slightly above 882.4 K in 2024.Similar Executives
Found 10 records | INSIDER Age | ||
Jon Morrison | Altagas Cum Red | N/A | |
Randall Crawford | Altagas Cum Red | 60 | |
Jenny Chou | European Residential Real | N/A | |
Corine Bushfield | Altagas Cum Red | 48 | |
Joy Thakur | Altagas Cum Red | N/A | |
Esq BComm | Altagas Cum Red | N/A | |
Phillip Burns | European Residential Real | 55 | |
Kent Stout | Altagas Cum Red | N/A | |
Janet CA | Aptose Biosciences | N/A | |
James Shelford | Altagas Cum Red | 39 |
Management Performance
Return On Equity | -98.1 | ||||
Return On Asset | -1.48 |
Sirona Biochem Corp Leadership Team
Elected by the shareholders, the Sirona Biochem's board of directors comprises two types of representatives: Sirona Biochem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sirona. The board's role is to monitor Sirona Biochem's management team and ensure that shareholders' interests are well served. Sirona Biochem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sirona Biochem's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CGA, CFO Director | ||
Graldine DeliencourtGodefroy, Chief Director | ||
Michelle MBA, VP Operations | ||
Brett Premack, Scientific Consultant |
Sirona Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sirona Biochem a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -98.1 | ||||
Return On Asset | -1.48 | ||||
Operating Margin | (258.82) % | ||||
Current Valuation | 23.99 M | ||||
Shares Outstanding | 258.84 M | ||||
Shares Owned By Insiders | 10.56 % | ||||
Number Of Shares Shorted | 93.61 K | ||||
Price To Book | 41.64 X | ||||
Price To Sales | 456.22 X | ||||
Revenue | 34.78 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sirona Stock Analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.